Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00069225 · ClinicalTrials.gov registry record

Brain Structure and Function Before and After Treatment for Post-Traumatic Stress Disorder

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
95
Enrollment target

NCT00069225: Completed study, sponsored by National Institute of Mental Health (NIMH).

NCT00069225 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 95 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00069225 has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
95 participants
Enrollment target

Study Summary

This study, conducted at the University of Pennsylvania and at the National Institutes of Health in Bethesda, Maryland, will examine deficits in brain structure and function in people exposed to trauma who developed post-traumatic stress disorder (PTSD) to see if these deficits change after treatment. It also will investigate whether there is a genetic susceptibility to PTSD. Candidates 18 years of age and older in the following categories will be included in this study: 1) women who have PTSD of at least 1 year's duration following sexual or non-sexual assault; 2) healthy women (controls) who were previously assaulted but did not develop PTSD; and 3) healthy women (controls) who were never traumatized. Candidates will be screened with a medical history and physical examination, psychiatric evaluation, electrocardiogram (EKG), and routine blood and urine tests. Women with PTSD will be assigned to receive either: 1) 12 weeks of cognitive behavioral psychotherapy either immediately upon enrollment or after a 3-month waiting period; or 2) 10 weeks of drug treatment with paroxetine (Paxil® (Registered Trademark)). Patients will be evaluated before and after treatment with the procedures outlined below. Control subjects will undergo the same procedures, also with a 10- to 12-week interval between evaluations. * Neuropsychological testing: Subjects will take paper and pencil and computer tests to evaluate memory, learning, attention and concentration, vocabulary and naming. * Magnetic resonance imaging (MRI): Subjects will have MRI scans of the brain to examine brain structure and blood flow while they perform two tasks. In the first task, they will be shown a series of faces and asked to press one button for a male face and another button for a female face. In the second task they will hear loud noises and see colored squares. During the scan, subjects lie on a bed that slides into a narrow tunnel (the scanner). They will wear a headset to block the noise of the scann

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2003-09
Est. Completion 2005-09

What the finished NCT00069225 record still lists

NCT00069225 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 95 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00069225 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00069225 about?

NCT00069225 is a clinical study titled "Brain Structure and Function Before and After Treatment for Post-Traumatic Stress Disorder". This study, conducted at the University of Pennsylvania and at the National Institutes of Health in Bethesda, Maryland, will examine deficits in brain structure and function in people exposed to trauma who developed post-traumatic stress disorder (PTSD) to see if these deficits change after treatmen...

What is the current status of trial NCT00069225?

This trial is currently completed. The enrollment target is 95 participants. The study started on 2003-09. Estimated completion is 2005-09.

Who is sponsoring clinical trial NCT00069225?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03339128 · 95 participants · Phase 2

    Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

  • NCT03509961 · 95 participants · Phase 2

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • NCT03694756 · 95 participants · NA

    TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

  • NCT04206215 · 95 participants · NA

    Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00069225, the US trial registry maintained by the National Library of Medicine. NCT00069225 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.